The efficacy of topical metronidazole in the treatment of ocular rosacea. 1996

D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
Division of Ophthalmology, Cleveland Clinic Foundation, OH 44195, USA.

OBJECTIVE The purpose of the study is to investigate the efficacy of metronidazole topical gel in the treatment of ocular rosacea. METHODS Ten patients with ocular rosacea were treated prospectively with lid hygiene and topical metronidazole applied to the lid margin in one eye and lid hygiene alone in the fellow eye. The treatment period was 12 weeks. A masked observer graded the ocular findings at the initial visit and at the conclusion of the treatment period. Pretreatment scores were compared with post-treatment scores with respect to ocular surface, eyelid margin, and combined eyelid plus ocular surface. RESULTS Eight of ten treated eyes improved, whereas only five of ten control eyes improved. There was a statistically significant improvement in the eyelid score in both the treated and control groups (P = 0.003, P = 0.025, respectively), but no significant improvement in the ocular surface score in either group. When the pretreatment and post-treatment eyelid and ocular surface scores were combined, there was a significant improvement in the treated eyes but not in the control eyes (P = 0.022, P = 0.10, respectively). No adverse effects of the metronidazole treatment were encountered in this study. CONCLUSIONS Metronidazole topical gel may be a safe and effective means of treating rosacea blepharitis.

UI MeSH Term Description Entries
D008297 Male Males
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001762 Blepharitis Inflammation of the eyelids. Blepharitides
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005782 Gels Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
September 1986, Cutis,
D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
June 2009, Advances in therapy,
D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
August 1989, The Medical letter on drugs and therapeutics,
D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
January 2002, Skin therapy letter,
D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
January 2004, Cutis,
D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
August 2021, Ocular immunology and inflammation,
D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
May 1987, Archives of dermatology,
D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
June 1998, Archives of dermatology,
D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
April 1987, Drug intelligence & clinical pharmacy,
D A Barnhorst, and J A Foster, and K C Chern, and D M Meisler
January 1988, International journal of dermatology,
Copied contents to your clipboard!